Contineum Therapeutics, Inc. Class A Common Stock share price logo

Contineum Therapeutics, Inc. Class A Common Stock Share Price

NASDAQ: CTNM

Small Cap

$13.53

+0.22

(+1.69%)

as on

Contineum Therapeutics, Inc. Class A Common Stock Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $12.80
    $13.45
    downward going graph

    5.40%

    Downside

    -0.59%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.35
    $16.33
    downward going graph

    75.24%

    Downside

    20.69%

    Upside

    downward going graph

Contineum Therapeutics, Inc. Class A Common Stock share price movements today

Previous Close
$13.30
Open
$13.25
Volume
760.4K
Day's Low - High
$12.80 - $13.45
52 Week Low - High
$3.35 - $16.33

Contineum Therapeutics, Inc. Class A Common Stock Historical Returns

1 Month Return
+ 10.72 %
3 Month Return
+ 15.25 %
1 Year Return
+ 192.86 %
3 Year Return
0 %
5 Year Return
0 %

Contineum Therapeutics, Inc. Class A Common Stock Stock Fundamentals & Key Indicators

Check Contineum Therapeutics, Inc. Class A Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$505.2M

EPS (TTM)

-2.0557

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-26.13%

Contineum Therapeutics, Inc. Class A Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Contineum Therapeutics, Inc. Class A Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Contineum Therapeutics, Inc. Class A Common Stock image
Contineum Therapeutics, Inc. Class A Common Stock
NA$505.2MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.3B122.97%133.478.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B101.1%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$37.2BNA131.655.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B49.34%17.9831.41%

Stock Returns calculator for Contineum Therapeutics, Inc. Class A Common Stock Stock including INR - Dollar returns

The Contineum Therapeutics, Inc. Class A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Contineum Therapeutics, Inc. Class A Common Stock investment value today

Current value as on today

₹3,17,252

Returns

₹2,17,252

(+217.25%)

Returns from Contineum Therapeutics, Inc. Class A Common Stock Stock

₹1,92,857 (+192.86%)

Dollar Impact

₹24,395 (+24.39%)

Contineum Therapeutics, Inc. Class A Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
0
-
-
-
-
Gross Profit
-
0
0
0
-
0
-
0
0
0
Operating Income
-8
-9
-9
-10
-12
84
-18
-17
-14
-17
EBITDA
-6
-7
-9
-8
-10
-14
-18
-15
-12
-17
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-6
-7
-8
-9
-10
-14
-15
-16
-12
-15
Income Tax Expense
0
0
-
-
-
-
-
-
-
-
Net Income
-6
-7
-8
-9
-10
-14
-15
-16
-12
-15
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-6018.60%
0.00%
0.00%
0.00%
0.00%

Contineum Therapeutics, Inc. Class A Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
50
-
-
Gross Profit
-
0
50
0
0
Operating Income
-28
-22
-16
-50
-68
EBITDA
-28
-23
23
-42
-68
Interest Expense
0
0
0
-
-
Depreciation
0
0
0
0
0
Income Before Tax
-29
-24
23
-42
-59
Income Tax Expense
0
-
0
-
-
Net Income
-29
-24
22
-42
-59
Net Profit Margin
0.00%
0.00%
45.44%
0.00%
0.00%

Contineum Therapeutics, Inc. Class A Common Stock Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-7
-8
-9
-10
-14
-15
-16
-12
-15
Operating Cash Flow
-10
-8
-8
-6
-10
-14
-15
-12
-13
Investing Cash Flow
9
8
-38
-30
-9
14
13
14
-47
Financing Cash Flow
0
0
108
0
0
0
0
19
93
Change in Cash
-1
0
60
-36
-18
0
-1
21
32

Contineum Therapeutics, Inc. Class A Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
22
-42
-59
Operating Cash Flow
-20
19
-32
-55
Investing Cash Flow
22
-65
-69
-3
Financing Cash Flow
-1
56
109
112
Change in Cash
0
9
6
53

Insights on Contineum Therapeutics, Inc. Class A Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CTNM has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, CTNM stock has moved up by 192.9%

About Contineum Therapeutics, Inc. Class A Common Stock

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company's lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.
OrganisationContineum Therapeutics, Inc. Class A Common Stock
Headquarters3565 General Atomics Court, San Diego, CA, United States, 92121
IndustryBiotechnology
CEOMr. Carmine N. Stengone MBA, MS
E-voting on sharesClick here to vote

Key Management of Contineum Therapeutics, Inc. Class A Common Stock

Name

Title

Mr. Austin Chen Ph.D.

Senior VP & Head of Research

Ms. Julie S. Iwashita

Senior Vice President of Clinical Operations

Mr. Peter T. Slover CPA

Chief Financial Officer

Dr. Daniel S. Lorrain Ph.D.

Chief Science Officer

Mr. Steve E. Kunszabo

Senior Director of Investor Relations & Corporate Communications

Ms. Jennifer Patterson

Vice President of Human Resources

Mr. Carmine N. Stengone MBA, MS

President, CEO & Director

Mr. John S. Healy

General Counsel & Corporate Secretary

Ms. Morgan Paulsen

Senior Manager of Accounting

Dr. Timothy R. Watkins M.D., M.Sc.

Chief Medical Officer & Head of Development

FAQs

What is Contineum Therapeutics, Inc. Class A Common Stock share price today?

Contineum Therapeutics, Inc. Class A Common Stock share price today is $13.53 as on at the close of the market. Contineum Therapeutics, Inc. Class A Common Stock share today touched a day high of $13.45 and a low of $12.8.

What is the 52 week high and 52 week low for Contineum Therapeutics, Inc. Class A Common Stock share?

Contineum Therapeutics, Inc. Class A Common Stock share touched a 52 week high of $16.33 on and a 52 week low of $3.35 on . Contineum Therapeutics, Inc. Class A Common Stock stock price today i.e. is closed at $13.53,which is 17.15% down from its 52 week high and 303.88% up from its 52 week low.

What is Contineum Therapeutics, Inc. Class A Common Stock's market capitalisation today?

Contineum Therapeutics, Inc. Class A Common Stock market capitalisation is $0.00T as on .

How to invest in Contineum Therapeutics, Inc. Class A Common Stock Stock (CTNM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Contineum Therapeutics, Inc. Class A Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Contineum Therapeutics, Inc. Class A Common Stock Shares that will get you 0.1109 shares as per Contineum Therapeutics, Inc. Class A Common Stock share price of $13.53 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Contineum Therapeutics, Inc. Class A Common Stock Stock (CTNM) from India?

Indian investors can start investing in Contineum Therapeutics, Inc. Class A Common Stock (CTNM) shares with as little as ₹92.575 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹925.75 in Contineum Therapeutics, Inc. Class A Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Contineum Therapeutics, Inc. Class A Common Stock share’s latest price of $13.53 as on April 18, 2026 at 1:29 am IST, you will get 0.7391 shares of Contineum Therapeutics, Inc. Class A Common Stock. Learn more about fractional shares .